Catalyst Pharmaceuticals Inc

CPRX NASDAQ Santé & Biotech États-Unis US14888U1016
31.36 $

Catalyst Pharmaceuticals Inc développe et commercialise des médicaments pour le traitement de maladies neurologiques rares et compliquées, notamment la myasthénie grave.

Performance & Momentum

6 Months 29.69 %
1 Year 33.28 %
3 Years 168.72 %
5 Years 447.29 %

Similar stocks to Catalyst Pharmaceuticals Inc

Anantys Community

Be the first to share your analysis on Catalyst Pharmaceuticals Inc.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases